TAFRO syndrome complicated by porto-sinusoidal vascular liver disease with portal hypertension: a case report

Clin J Gastroenterol. 2021 Dec;14(6):1711-1717. doi: 10.1007/s12328-021-01515-2. Epub 2021 Sep 6.

Abstract

Porto-sinusoidal vascular liver disease (PSVD) is a disorder that can cause portal hypertension without liver cirrhosis. TAFRO syndrome is a systemic inflammatory disorder with a background of immunological abnormalities. We report a case of TAFRO syndrome complicated by PSVD with portal hypertension. A 39-year-old man developed refractory ascites and esophageal varices. Lymph node histology revealed multicentric Castleman disease-like features. Intravenous methylprednisolone and tocilizumab therapy improved ascites and renal dysfunction, but the patient developed severe infections. The diagnosis of TAFRO syndrome in patients complicated by PSVD with portal hypertension encourages the consideration of appropriate treatment for these patients.

Keywords: Ascites; Idiopathic noncirrhotic portal hypertension; Porto-sinusoidal vascular liver disease; TAFRO syndrome; Tocilizumab.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Castleman Disease*
  • Humans
  • Hypertension, Portal* / complications
  • Liver Cirrhosis / complications
  • Male
  • Vascular Diseases*

Supplementary concepts

  • Multi-centric Castleman's Disease